Tactical Therapeutics, Inc. And Investigators To Present CTO Results At The Annual ASCO Meeting
NEW YORK--(BUSINESS WIRE)--Tactical Therapeutics, Inc., a clinical stage oncology drug development company, announced today it is scheduled to present study results of its lead drug Carboxyamidotriazole Orotate (CTO) at the annual American Society of Clinical Oncology meeting taking place May 29th to June 2nd in Chicago, Illinois.
Help employers find you! Check out all the jobs and post your resume.
Help employers find you! Check out all the jobs and post your resume.